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Background: Up to now, few data are available regarding the clinical characteristics of autoimmune hepatitis and
primary biliary cirrhosis overlap syndrome. The study was to investigate and analyze the prevalent and clinical
features of Chinese patients with this disease.
Methods: Clinical data on patients diagnosed as autoimmune hepatitis and primary biliary cirrhosis overlap
syndrome in our hospital from January 2001 to December 2006 were collected and analyzed.
Results: Overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis accounted for 10.33% of patients with
autoimmune liver diseases during the past six years. For these patients with overlap syndrome, xanthochromia, lethargy
and anorexia were the predominant complaints; a low incidence (14/146) of smooth muscle antibody positivity and a
high incidence (37/89) of isolated IgM elevation were the main serological characteristics.
Conclusions: Overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis was not rare in Chinese
patients with clinical manifests of autoimmune liver diseases. Overlap of the diseases should not be disregarded
when isolated IgM elevation was exhibited, and smooth muscle antibody might have little diagnostic significance
in the overlap syndrome. If it was difficult to make a definite diagnosis, liver biopsy was necessary.
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1. Background
Autoimmune hepatitis (AIH), primary biliary cirrhosis
(PBC), and primary sclerosing cholangitis (PSC) are three
major clinicopathologic entities of autoimmune liver dis-
eases. Besides, some patients with autoimmune liver dis-
ease present with characteristics of a second autoimmune
liver disease (i.e. AIH and PBC overlapping). These cases
have been defined as overlap syndrome. Patients with
overlap syndrome usually present with nonspecific symp-
toms, including lethargy, arthralgias, and myalgias. A com-
bination of clinical and laboratory or pathologic criteria is
necessary for the diagnosis of the disease. In the laboratory
test, autoantibodies are the serological hallmarks. Serum
antinuclear antibody (ANA), smooth muscle antibody
(SMA) and antimitochondrial antibody (AMA) are routi-
nely detected in these patients [1].
Although combined features of both PBC and PSC
have been reported in single cases, there is no clear evi-
dence for the existence of an overlap of PBC and PSC [2].
The overlap syndrome of AIH and PBC is the most com-
mon form, and it shows a more progressive course
towards liver cirrhosis and liver failure than AIH or PBC
alone [3-5]. However, up to now, the pathogenesis of
overlap syndrome is poorly understood [6], and few data
are available regarding the clinical characteristics of this
disease, and moreover, reports on the prevalent and sero-
l o g i c a lf e a t u r e so ft h i sc o n d i tion in Chinese population
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investigate and analyze the prevalent and clinical features
of Chinese patients with AIH and PBC overlap syndrome.
2. Methods
2.1. Patients
Patients diagnosed as overlap syndrome of AIH and PBC
in 302 hospital from January 2001 to December 2006 were
included in the retrospective study. The diagnosis was
based on the criteria established by Chazouillères O, et al
[7]. Exclusion criteria included coinfection with hepatitis
A, C, D, E, Epstein-Barr virus, cytomegalovirus or HIV;
the presence of other forms of liver diseases such as alco-
holic liver disease, drug hepatitis or Wilson’s disease. 146
patients were eventually enrolled in our study. Informed
written consent for the analysis was obtained from each
patient. The study was approved by the ethics committee
of Beijing 302 Hospital.
2.2. Serological markers and liver histopathology
Serum autoantibodies, including antinuclear antibody
(ANA), smooth muscle antibody (SMA) and antimitochon-
drial antibody (AMA) were tested using indirect immuno-
fluorescence with the standard methods (Euroimmun
Medizinnische Labordiagnostika AG, Germany), and sera
were considered to be positive when they produced a reac-
tion at a dilution of ≥ 1:100. Immunoglobulin (Ig) assay
were taken with the mothod of immunological turbidime-
try (Diasys Diagnostic Systems, China). The normalized
levels of IgG, IgM and IgA were respectively 7.23-16.6 g/L,
0.63-2.77 g/L and 0.69-3.82 g/L.
Biochemical profiles, including alanine transarninase
(ALT), aspartate aminotransferase (AST), total bilirubin
(TBil), gamma glutamyl transferase (GGT) and alkaline
phosphatase (ALP) were measured using standard labora-
tory procedure. The normalized levels of ALT, AST, TBil,
GGT and ALP were respectively < 40 U/L, < 40 U/L,
< 17.1 umol/L, 7-32 U/L, and 40-150 U/L.
Liver biopsy was performed in some cases for definite
diagnosis, and biopsy specimens were examined in the
Pathology Department.
2.3. Statistical analysis
Data analysis were performed using SAS 9.2 software
(SAS Institute Inc., Cary, NC, USA) and the quantitative
data were expressed as mean and standard deviation.
3. Results
3.1. Baseline characteristics and prevalent features
In this six-year retrospective survey based on our hospi-
tal, a total of 1413 patients was diagnosed as autoim-
mune liver diseases, of which, 577 were AIH, 685 were
PBC, 5 were PSC, 146 were overlap syndrome of AIH
and PBC, and none were overlap syndrome of AIH and
PSC. Overlap syndrome of AIH and PBC accounts for
10.33% of patients with autoimmune liver diseases, and
this proportion was similar to that in previous reports
in India and France [8,9]. The characteristics of the 146
patients at the diagnosis of overlap syndrome of AIH
and PBC were described in Table 1.
3.2. Clinical features
We viewed the 146 case histories, and found that, as the
chief complaints at the diagnosis, xanthochromia occurs
in 86 patients, with the incidence of 58.90%; lethargy
occurs in 79 patients, with the incidence of 54.11%;
anorexia occurs in 75 patients, with the incidence of
51.37%; pruritus occurs in 51 patients, with the inci-
dence of 34.93%; discomfort in hepatic region occurs in
33 patients, with the incidence of 22.60%; arthralgias or
myalgias occurs in 33 patients, with the incidence of
22.60%; asymptomatic elevation of serum liver enzymes
occurs in 20 patients, with the incidence of 13.70%; sple-
nomegaly occurs in 12 patients, with the incidence of
8.22%. Details were summarized in Table 2.
Of the 146 patients, 140 had positive ANA, accounting
for 95.89%; 129 had positive AMA, accounting for
88.36%; 14 had positive SMA, accounting for 9.59%.
Details were seen in Table 3.
A total of 89 patients with immunoglobulin assay was
identified. Of these patients, 37 had isolated IgM eleva-
tion, accounting for 41.57%; 17 had isolated IgG eleva-
tion, accounting for 19.10%; 23 had both IgM and IgG
elevation, accounting for 25.84%; 12 had neither IgM
nor IgG elevation, accounting for 13.48%. The results
were summarized in Table 4.
58 patients underwent liver biopsy. Diagnostic patholo-
gical changes, including bile duct lesion, interface hepati-
tis and plasma cell infiltration were observed in all
patients. Summarization of the pathological features for
these patients was seen in Yanling Sun’s previous study
Table 1 Characteristics of patients at the diagnosis of
AIH and PBC overlap syndrome
Value
sex: female/male 125/21
age (years) 46.50 ± 10.08
TBil (umol/L) 43.08 ± 27.94
ALT (U/L) 116.80 ± 37.10
AST (U/L) 77.02 ± 32.75
GGT (U/L) 369.12 ± 329.32
ALP (U/L) 399.40 ± 221.53
IgM 3.91 ± 2.08
IgG 18.79 ± 1.56
n = 146
ALT, alanine transarninase; AST, aspartate aminotransferase; TBil, total
bilirubin; GGT, gamma glutamyl transferase; ALP, alkaline phosphatase; Ig,
immunoglobulin.
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overlap syndrome were shown in Figure 1.
4. Discussion
The worldwide prevalence of overlap syndrome of AIH
and PBC is unknown. The first cases of this disease were
reported almost 30 years ago, and this entity was assumed
to be rare [11]. However, in our hospital, 10.33% of
patients with autoimmune liver diseases were diagnosed as
overlap syndrome of AIH and PBC based on the clinical
manifests, laboratory test, and liver biopsy during the six
years. Our study also showed that, similar to other studies
[12,13], overlap syndrome of AIH and PBC was more
common in female patients, with a female:male ratio of
roughly 6:1. However, the median age of patients with
overlap syndrome was older than that of a previous report
about European patients [9].
Presentation of autoimmune liver diseases varies widely,
ranging from asymptomatic elevations of serum liver
enzymes to massive hepatic necrosis resulting in fulminant
hepatic failure, and there are no disease-specific clinical
features. Günsar F, et al [14] reported that, lethargy was
the most common symptom in these patients. Our study
showed that xanthochromia, lethargy and anorexia were
the predominant three chief complaints, that was, besides
lethargy, xanthochromia was also a most common symp-
tom in Chinese patients with overlap syndrome of AIH
and PBC.
Serum autoantibodies have steadily established them-
selves as critical biomarkers for the diagnosis of autoim-
mune diseases [15]. For the North-American and European
population, ANA and SMA constitute the standard reper-
toire for the diagnosis of autoimmune hepatitis, and AMA
is the diagnostic marker of primary biliary cirrhosis [7,16].
In our study, the majority of patients had positive serum
ANA (140/146) and AMA (129/146), whereas only minor
patients (14/146) had positive serum SMA. This result
showed that, there was a low incidence of positive serum
SMA in Chinese patients with overlap syndrome of AIH
and PBC, which might indicate that serum SMA may have
little diagnostic significance in the overlap syndrome for
Chinese patients. This finding agreed with another investi-
gation performed by Zhenxia Liu [17].
Some studies had shown that the serum immunoglobu-
lins could elevate in most cases of autoimmune liver dis-
eases [18-22] and types of the elevated immunoglobulins
were distinctive in different categories of autoimmune
liver diseases. IgG was the predominant immunoglobulin
elevated in serum of AIH patients while IgM was elevated
in most patients with PBC [23-25]. However, in our study,
isolated IgM elevation was preponderant (37/89), which
presented with features of PBC. Previously, a German
Table 2 Chief complaints of patients at the diagnosis of
AIH and PBC overlap syndrome
Chief complaint Case Incidence (%)
Xanthochromia 86 58.90
Lethargy 79 54.11
Anorexia 75 51.37
Pruritus 51 34.93
discomfort in hepatic region 33 22.60
arthralgias or myalgiasg 33 22.60
asymptomatic elevation of serum liver
enzymes
20 13.70
splenomegaly 12 8.22
n = 146
Table 3 Features of autoantibodies in patients
Features No. Incidence (%)
ANA positive 140 95.89
AMA positive 129 88.36
SMA positive 14 9.59
both ANA and AMA positive 122 83.56
both SMA and AMA positive 10 6.85
n = 146
ANA, antinuclear antibody; AMA, antimitochondrial antibody; SMA, smooth
muscle antibody.
Table 4 Features of immunoglobulin (Ig) elevation in
patients
Features No. Percentage (%)
isolated IgM elevation 37 41.57
isolated IgG elevation 17 19.10
both IgM and IgG elevation 23 25.84
neither IgM nor IgG elevation 12 13.48
Total 89 100.00
Figure 1 Typical pathological changes (bile duct lesion,
interface hepatitis and plasma cell infiltration) in a Chinese
patient diagnosed as AIH and PBC overlap syndrome. (HE,
×200).
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and PBC presented with typical features of PBC when
compared to AIH and PBC patients [13]. The reason, we
inferred, might be that serological markers were often fea-
tured with one predominant pathological change to the
other in overlap syndrome. But how to distinguish the pre-
dominant one needed further studies.
5. Conclusion
Overlap syndrome of autoimmune hepatitis and primary
biliary cirrhosis was not rare in Chinese patients with clin-
ical manifests of autoimmune liver diseases. Overlap of the
diseases should not be disregarded when isolated IgM ele-
vation was exhibited, and smooth muscle antibody might
have little diagnostic significance in the overlap syndrome.
If it was difficult to make a definite diagnosis, liver biopsy
was necessary.
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